Sio Capital Management, LLC Larimar Therapeutics, Inc. Transaction History

Sio Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$8.0 - $15.2 $1.5 Million - $2.85 Million	-187,223 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$14.61 - $22.19 $21,009 - $31,909	-1,438 Reduced 0.76%	187,223 $2.74 Million
Q4 2020 Feb 16, 2021	SELL	$14.28 - $25.06 $1.6 Million - $2.8 Million	-111,930 Reduced 37.24%	188,661 $4.04 Million
Q3 2020 Nov 16, 2020	SELL	$10.5 - $17.6 $185,503 - $310,939	-17,667 Reduced 5.55%	300,591 $4.56 Million
Q2 2020 Aug 14, 2020	BUY	$0.72 - $16.76 $229,145 - $5.33 Million	318,258 New	318,258 $4.09 Million

128

67.3M

280K

76.3K

Ticker LRMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,269,200
Market Cap $174M
Description
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.